Question: Which startup has developed kits for testing asymptomatic COVID-19 infections & gears up for vaccine production?
(a) Seagull BioSolutions
(b) Genrich Membranes
(c) Zydus
(d) Ranbaxy
Answer: (a)
Related facts:
- DST funded startup has developed kits for testing asymptomatic COVID-19 infections & gears up for vaccine production.
- It was developed by Seagull BioSolutions.
Purpose to develop:
• Developing vaccines has the longest timeline and so it is essential to fast track that activity earlier.
Uses:
- Active Virosome Technology (AVT) developed by Seagull Bio is useful for the production of vaccines & immunotherapeutic agents.
- The AVT platform is useful for producing novel, non-hazardous & economical Active Virosome agents expressing desired antigens from the target pathogen.
- These will be used to develop a novel vaccine for the prevention of COVID-19 infection and also immunodiagnostic ELISA kits for COVID-19.
Seagull BioSolutions:
- Seagull BioSolutionsis a startup working on new biological technologies, is being funded by the Department of Science and Technology (DST).
By-Achyutanand Pandey
Links:
https://pib.gov.in/PressReleseDetail.aspx?PRID=1613213